372 related articles for article (PubMed ID: 11920678)
41. [Neurobiological principles of drug dependence. Exemplified by opioids and psychostimulants].
Herz A
Nervenarzt; 1995 Jan; 66(1):3-14. PubMed ID: 7885510
[TBL] [Abstract][Full Text] [Related]
42. Identification of chronic cocaine-induced gene expression through dopamine d1 receptors by using cDNA microarrays.
Zhang J; Zhang D; Xu M
Ann N Y Acad Sci; 2002 Jun; 965():1-9. PubMed ID: 12105080
[TBL] [Abstract][Full Text] [Related]
43. [Evolution and development of dopaminergic neurotransmitter systems in vertebrates].
Kapsimali M; Dumond H; Le Crom S; Coudouel S; Vincent JD; Vernier P
J Soc Biol; 2000; 194(2):87-93. PubMed ID: 11098433
[TBL] [Abstract][Full Text] [Related]
44. Do D2-like dopamine receptors mediate neuronal excitation or inhibition: some functional-behavioural implications.
Waddington JL
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):111-2. PubMed ID: 9201733
[TBL] [Abstract][Full Text] [Related]
45. Localization of neurochemical effects of cocaine and other stimulants in the human brain.
Baxter LR; Schwartz JM; Phelps ME; Mazziotta JC; Barrio J; Rawson RA; Engel J; Guze BH; Selin C; Sumida R
J Clin Psychiatry; 1988 Feb; 49 Suppl():23-6. PubMed ID: 3257485
[TBL] [Abstract][Full Text] [Related]
46. Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.
Angelucci F; Ricci V; Spalletta G; Caltagirone C; Mathé AA; Bria P
Int Rev Neurobiol; 2009; 88():1-24. PubMed ID: 19897072
[TBL] [Abstract][Full Text] [Related]
47. The role of CART in the reward/reinforcing properties of psychostimulants.
Jaworski JN; Jones DC
Peptides; 2006 Aug; 27(8):1993-2004. PubMed ID: 16766084
[TBL] [Abstract][Full Text] [Related]
48. Dopamine D₁-D₂ receptor heteromer regulates signaling cascades involved in addiction: potential relevance to adolescent drug susceptibility.
Perreault ML; O'Dowd BF; George SR
Dev Neurosci; 2014; 36(3-4):287-96. PubMed ID: 24820626
[TBL] [Abstract][Full Text] [Related]
49. Monoaminergic regulation of neuroendocrine function and its modification by cocaine.
Levy AD; Baumann MH; Van de Kar LD
Front Neuroendocrinol; 1994 Jun; 15(2):85-156. PubMed ID: 7813744
[TBL] [Abstract][Full Text] [Related]
50. [Cocaine: historical background, neurobiology of the addiction and relapse and therapeutic perspectives].
Silva MI; Citó MC; Vasconcelos PF; Vasconcelos SM; Sousa FC
Acta Med Port; 2010; 23(2):247-58. PubMed ID: 20470473
[TBL] [Abstract][Full Text] [Related]
51. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research.
Ritz MC; Kuhar MJ
Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741
[TBL] [Abstract][Full Text] [Related]
52. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction.
Nonkes LJ; van Bussel IP; Verheij MM; Homberg JR
Behav Pharmacol; 2011 Dec; 22(8):723-38. PubMed ID: 22015806
[TBL] [Abstract][Full Text] [Related]
53. Probing the role of the dopamine D1 receptor in psychostimulant addiction.
Zhang J; Walsh RR; Xu M
Ann N Y Acad Sci; 2000 Sep; 914():13-21. PubMed ID: 11085304
[TBL] [Abstract][Full Text] [Related]
54. Cocaethylene: pharmacologic activity and clinical significance.
Jatlow P
Ther Drug Monit; 1993 Dec; 15(6):533-6. PubMed ID: 8122289
[TBL] [Abstract][Full Text] [Related]
55. Central stimulant abuse: neurochemistry and pharmacotherapy.
Dackis CA; Gold MS; Pottash AL
Adv Alcohol Subst Abuse; 1986; 6(2):7-21. PubMed ID: 2886014
[TBL] [Abstract][Full Text] [Related]
56. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
Howell LL; Cunningham KA
Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
[TBL] [Abstract][Full Text] [Related]
57. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies.
Vanderschuren LJ; Kalivas PW
Psychopharmacology (Berl); 2000 Aug; 151(2-3):99-120. PubMed ID: 10972458
[TBL] [Abstract][Full Text] [Related]
58. The pharmacology and neural circuitry of sensitization to psychostimulants.
Kalivas PW; Sorg BA; Hooks MS
Behav Pharmacol; 1993; 4(4):315-334. PubMed ID: 11224200
[TBL] [Abstract][Full Text] [Related]
59. Cocaine Addiction: Neurobiology and Related Current Research in Pharmacotherapy.
Panikkar GP
Subst Abus; 1999 Sep; 20(3):149-166. PubMed ID: 12511828
[TBL] [Abstract][Full Text] [Related]
60. Molecular and regional targets of cocaine in primate brain: liberation from prosaic views.
Madras BK; Miller GM; Meltzer PC; Brownell AL; Fischman AJ
Addict Biol; 2000 Jul; 5(3):351-9. PubMed ID: 20575852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
